Established:

2006

Employees:

25

Location:

Tartu

Distinctiveness:

TBD-Biodiscovery is a GMP-certified service provider for pharma/biotech industry. The company has two pipelines of products – bioluminescence compounds (Ultra-high grade D-Luciferin) and payloads for Antibody Drug Conjugates.

Services:

Contract research (synthesis services, process development), analytical services, contract manufacturing of active pharmaceutical ingredients

Areas of activity:

TBD-Biodiscovery contributes to modern anti-cancer drug development, innovative diagnostics methods and smart solutions for chemical and agrochemical industry. The company has strong experience in a synthesis route design, process development and complex multistep synthesis, offering also GMP-certified production of active pharmaceutical ingredients. TBD-Biodiscovery is one of the biggest manufacturers of Ultrahigh grade D-Luciferin, used as bioluminescence dye in cancer research. The company also develops original compounds for targeted anticancer treatment

Export markets:

EU, Switzerland, United States, Israel and Russia

Completed projects:

Semisynthetic technology of amrubicin synthesis (patented); next generation of Antibody Drug Conjugates (ADC) for cancer therapy (MABTOX project supported by EU 7th framework programme); original payloads for ADC (patent application filed)

Clients:

From small biotech to big pharma companies

Partner:

Competence Centre on Health Technologies.